APSFA Medical Advisory Board
Doruk Erkan, MD, MPH
Associate Physician-Scientist at the Barbara Volcker Center for Women and Rheumatic Diseases
Associate Professor of Medicine at Weill Cornell Medical College
In addition to his rheumatology practice, Dr. Erkan has a long-standing research interest in Antiphospholipid Syndrome (an autoimmune clotting disorder) and Systemic Lupus Erythematosus (SLE or “lupus”). After his Internal Medicine residency at Beth Israel Medical Center in New York, he completed his Rheumatology fellowship at Hospital for Special Surgery in New York. Dr. Erkan has a medical doctor (MD) degree from Hacettepe University School of Medicine in Ankara, Turkey and a master of public health (MPH) degree from Johns Hopkins University School of Public Health in Baltimore, Maryland. Learn more.
Jason Knight, MD, PhD
University of Michigan
Dr. Knight received his MD and PhD degrees from the University of Michigan, and completed his molecular biology Ph.D. research in the laboratory of Dr. Erle Robertson at the University of Pennsylvania. His fellowship in rheumatology was at the University of Michigan, where he received the prestigious American College of Rheumatology Distinguished Fellow Award, as well as a Rheumatology Research Foundation Scientist Development Award. As a faculty member, he has been awarded a Young Physician Scientist Award by the American Society of Clinical Investigation, and a Vic and Kelly Braden Memorial Grant for Lupus Research by the Arthritis National Research Foundation.
Dr. Knight is a leader nationally in the clinical care of APS patients, and especially the role of inflammation in APS. His NIH-funded research laboratory is working to better understand the triggers and effectors of autoimmunity in lupus and the related antiphospholipid syndrome (APS). Contact Dr. Knight if you are interested in participating in APS research studies. Learn more.
Thomas L. Ortel, MD, PhD
Chief – Division of Hematology in the Department of Medicine
Professor of Pathology
Member of the Duke Cancer Institute
Dr. Ortel’s research interests focus on the diagnosis and treatment of patients with bleeding and clotting disorders. He is particularly interested in the immune-mediated clotting disorders, antiphospholipid syndrome (APS) and heparin-induced thrombocytopenia (HIT). Dr. Ortel has participated in multiple studies investigating new anticoagulants (blood thinners) and the use of these therapies in high-risk clinical situations (for example, in the perioperative state and in patients with cancer). His laboratory investigates the mechanisms of clotting and evaluating new anticoagulants. Learn more.
Barry L Myones, MD
Texas Children’s Hospital
Associate Professor, Pediatrics, Baylor College of Medicine
Dr. Barry Myones is a pediatric rheumatologist in Sugar Land, Texas and is affiliated with Texas Children’s Hospital. He received his medical degree from Albany Medical College and has been in practice for more than 20 years. Dr. Myones is one of 5 doctors at Texas Children’s Hospital who specialize in Pediatric Rheumatology. Learn more
Robert A. S. Roubey, MD
Division of Rheumatology & Immunology
University of North Carolina at Chapel Hill
Dr. Roubey’s laboratory focuses on the antiphospholipid syndrome, an autoimmune disease in which autoantibodies with an apparent specificity for anionic phospholipids are associated with arterial and venous thrombosis, pregnancy failure, and certain other manifestations. Dr. Roubey is also the Principle Investigator of the Antiphospholipid Syndrome Collaborative Registry (APSCORE), an NIH-funded multicenter disease registry based here at UNC-CH. APSCORE is collecting detailed clinical data and tissue specimens from 2,000 patients with antiphospholipid antibodies and the antiphospholipid syndrome. Registry data and resources will support numerous immunological studies, genetic analyses, and clinical trials.
Christopher Repetsky, MD
A native of Cleveland, Ohio, Dr. Repetsky attended the University of Akron for his undergraduate studies. He is a summa cum laude graduate of the American University of Antigua College of Medicine. His professional interests include Primary Care, Neurology, and the application of science-based medicine.
Are you a physician or researcher and wish to join our Medical Advisory board?
Our Mission
Founded in 2005, the APS Foundation of America, Inc. is dedicated to fostering and facilitating joint efforts in the areas of education, public awareness, research, and patient services for Antiphospholipid Syndrome (APS) in an effective and ethical manner.
Information Sheets
DISCLAIMER: The APS Foundation of America, Inc. website is not intended to replace standard doctor-patient visits, physical examination, and medical testing. Information given to members is only an opinion. All information should be confirmed with your doctor. Always seek a trained physician's advice before seeking any new treatment regarding your medical diagnosis or condition. Any information received from the APS Foundation of America, Inc. website is not intended to diagnose, treat, or cure. This site is for informational purposes only. Please note that we will list all donors' or purchasers' names on the donor page of our foundation site. If you do not want your name listed, please get in touch with us to opt-out. If you think you may have a medical emergency, call your doctor or 911 immediately.